Mechanism of oncogenicity for bioreductive drugs
- 31 December 1992
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (4) , 747-750
- https://doi.org/10.1016/0360-3016(92)90516-k
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Oncogenic transforming potential of nitroimidazole radiosensitizersInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Structure-activity relationships for benzotriazine DI-N-oxidesInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Nitroimidazole bioreductive metabolismBiochemical Pharmacology, 1987
- Oncogenic transformation of cells in culture: Pragmatic comparisons of oncogenicity, cellular and molecular mechanismsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analoguesInternational Journal of Radiation Oncology*Biology*Physics, 1986
- The effect of bioreduction on the oncogenicity of nitroimidazolesBiochemical Pharmacology, 1986
- In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizersInternational Journal of Radiation Oncology*Biology*Physics, 1985
- RSU 1069, a 2-nitroimidazole containing an alkylating group: High efficiency as a radio- and chemosensitizer in vitro and in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1984
- The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazolesInternational Journal of Radiation Oncology*Biology*Physics, 1982